Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Annular Rupture During TAVI
Author(s):
JJ Coughlan
,
Thomas J Kiernan
,
Darren Mylotte
,
et al
Added:
3 years ago
Article
Author(s):
Angela McInerney
,
Rafael Vera-Urquiza
,
Gabriela Tirado-Conte
,
et al
Added:
2 years ago
Author(s):
John Phineas O’Donnell
,
Crochan J O’Sullivan
Added:
3 years ago
The demand for replacing degenerated bioprosthetic valves (BPVs) is steadily rising owing to the increasing burden of heart disease, ageing populations, advances in surgical intervention and limited durability of current-generation surgical BPVs. The issue is exacerbated by the increasing trend of surgical BPV replacement, especially in younger patients who are likely to require future…
View more
Author(s):
Marco Barbanti
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) is an effective treatment for patients with severe aortic valve stenosis and high operative risk.1 Despite its widespread adoption across the world, this procedure is still associated with several complications.2 Many of these, because their relatively high frequency (conduction disturbances, vascular complications, cerebrovascular events,…
View more
Author(s):
Pierluigi Costanzo
,
Paul Bamborough
,
Mark Peterson
,
et al
Added:
1 year ago
Author(s):
Victoria Delgado
,
See Hooi Ewe
,
David Messika-Zeitoun
,
et al
Added:
3 years ago
Since the first-in-man experience by Cribier and co-workers,1 transcatheter aortic valve implantation (TAVI) has rapidly evolved, providing a feasible therapeutic alternative for patients with severe symptomatic aortic stenosis who have high-risk or contraindications to conventional surgery. The promising results of TAVI procedures reported by various registries2–6 were recently confirmed in the…
View more
Author(s):
Holger Eggebrecht
,
Axel Schmermund
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) has become a highly effective and beneficial treatment option for patients with severe symptomatic aortic valve stenosis. The randomized Placement of AoRtic TraNscathetER Valves (PARTNER) trials have shown that (1) TAVI using the balloon-expandable Edwards Sapien valve implanted via the transfemoral (TF) or transapical (TA) route is superior with…
View more
Author(s):
Alia Noorani
,
Vinayak Bapat
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) is an established alternative to surgical valve replacement in the management of calcified severe aortic stenosis in those with co-morbidities or adverse features (advanced age, impaired left ventricular function), or in those where open surgery may be associated with unfavourable technical features, such as previous sternotomy with a patent internal…
View more
Author(s):
Yusuke Watanabe
,
Ken Kozuma
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) is evolving rapidly with an exponential growth in the number of procedures in worldwide.1,2 As worldwide experience with this modality increases, more and more patients are being offered this alternative to open surgery for the treatment of severe, symptomatic aortic stenosis (AS). Although this technique has reached relative maturity, further…
View more